Concepedia

The clinical immunobiology of interleukin-2: potential modified uses for improved cancer treatment.

Stephan D. Voss, G Weil-Hillman, Jacquelyn A. Hank, Jeffrey A. Sosman, Paul M. Sondel

PubMed · 1989 · 62 citations · 46 references

Concepts

References

46

A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

Steven A. Rosenberg, Michael T. Lotze, Linda Muul et al. · New England Journal of Medicine · 1987 · 2.8K citations

, , +14

Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

Steven A. Rosenberg, Michael T. Lotze, Linda Muul et al. · New England Journal of Medicine · 1985 · 2.6K citations

, , +15

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

Doris A. Morgan, Francis W. Ruscetti, Robert C. Gallo · Science · 1976 · 2.5K citations

, , +10

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Elizabeth A. Grimm, A Mazumder, H Z Zhang et al. · The Journal of Experimental Medicine · 1982 · 2.2K citations · Full text

, , +15

Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis.

Joseph H. Phillips, Lewis L. Lanier · The Journal of Experimental Medicine · 1986 · 694 citations · Full text

, , +12